As the world waits and watches to see what the coronavirus does next, the bad old flu is getting a second wind in the U.S.—and children may be bearing the brunt.

Stroke survivors who are optimistic about their recovery demonstrate lower levels of inflammation and physical disability than their less-cheerful counterparts, researchers reported at the Nursing Symposium of the American Stroke Association’s International Stroke Conference.

A 92.6% reduction in the list price of tafamidis—an effective but ultimately unaffordable drug designed to treat transthyretin amyloid cardiomyopathy—would be required to make the medication accessible to the average heart patient, researchers reported in Circulation Feb. 12.

“This pioneering effort leverages evidence-based guidelines and the consensus of medical experts in a new and powerful way to optimize care for military veterans,” said Theodore L. DeWeese, MD, chair of ASTRO's board.

A Canadian clinical psychologist is repurposing a beta-blocker to ease the pain of emotional trauma, the BBC reports.

Philips is launching a new randomized controlled trial—dubbed DEFINE GPS—to assess patient outcomes after PCI guided by instant wave-Free Ratio measurements and angiograms. 

A shingles vaccine known as Zoster Vaccine Live can protect not only against a resurgence of the chickenpox virus, but also against stroke, according to research presented at the American Stroke Association’s International Stroke Conference this week in Dallas.

Medtronic and the FDA were both aware of battery and wire connection defects in a now-recalled heart failure pacemaker for over a year before patients developed serious side effects, according to a report published in JAMA Internal Medicine.